Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma.

Trial Profile

Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma.

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Mar 2011

At a glance

  • Drugs Dacarbazine; DHA-paclitaxel
  • Indications Malignant melanoma
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 16 Mar 2011 Actual end date (Oct 2007) added as reported by ClinicalTrials.gov.
    • 16 Mar 2011 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
    • 22 Aug 2007 Status change from recruiting to in progress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top